FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2954859619> ?p ?o ?g. }

• W2954859619 endingPage "366" @default.
• W2954859619 startingPage "356" @default.
• W2954859619 abstract "To assess whether radiographic and metabolic changes on midchemoradiation therapy (CRT) fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for cervical cancer predict outcome.Women with International Federation of Gynecology and Obstetrics stage IB1-IVB cervical cancer treated with concurrent cisplatin-based CRT and brachytherapy were enrolled on a single-institution prospective clinical trial; FDG-PET/CT was obtained before CRT and at 30 to 36 Gy. Max and mean standard uptake values, metabolic tumor volume, and total lesion glycolysis (TLG) for the primary tumor and clinically involved lymph nodes from the pre-CRT and intra-CRT FDG-PET/CT were recorded. Clinical endpoints analyzed include overall survival (OS), disease-free survival (DFS), and rates of cervical recurrence (CR), nodal recurrence (NR), and distant metastasis (DM). FDG-PET/CT variables and other prognostic factors associated with clinical endpoints were identified via univariate Cox proportional hazards modeling and competing risk analysis.Thirty women were enrolled from 2012 to 2016. After a median follow-up of 24 months, 2-year rates of OS, DFS, DM, NR, and CR were 68% (95% confidence interval [CI], 51%-85%), 44% (95% CI, 26%-63%), 42% (95% CI, 23%-59%), 14% (95% CI, 4%-30%), and 10% (95% CI, 2%-24%), respectively. Intra-PET metrics and TLG across all PET scans were most consistently associated with OS, DFS, DM, and NR on univariate analysis. Intra-CRT TLG was associated with OS (hazard ratio [HR] 1.35; 95% CI, 1.15-1.55; P = .001), DFS (HR 1.19; 95% CI, 1.04-1.34; P = .018), and NR (HR 1.25; 95% CI, 1.10-1.40; P = .002). No absolute or relative changes between parameters of baseline and mid-CRT FDG-PET/CT were associated with disease outcomes on univariate analysis, with the exception of relative change in mean standard uptake values and CR (P = .004).In this group of patients with high-risk cervical cancer treated with CRT and brachytherapy, TLG and metabolic tumor volume on intra-CRT FDG-PET/CT was associated with OS. These metrics may provide an early signal for selective treatment intensification with either dose escalation or adjuvant chemotherapy." @default.
• W2954859619 created "2019-07-12" @default.
• W2954859619 creator A5009234970 @default.
• W2954859619 creator A5015237674 @default.
• W2954859619 creator A5045431626 @default.
• W2954859619 creator A5075569712 @default.
• W2954859619 creator A5078538616 @default.
• W2954859619 date "2019-10-01" @default.
• W2954859619 modified "2023-10-12" @default.
• W2954859619 title "Changes on Midchemoradiation Therapy Fluorodeoxyglucose Positron Emission Tomography for Cervical Cancer Are Associated with Prognosis" @default.
• W2954859619 cites W1866280000 @default.
• W2954859619 cites W1967687873 @default.
• W2954859619 cites W1969411880 @default.
• W2954859619 cites W1970452171 @default.
• W2954859619 cites W1972062490 @default.
• W2954859619 cites W1989696833 @default.
• W2954859619 cites W1989888708 @default.
• W2954859619 cites W1991901248 @default.
• W2954859619 cites W2033894528 @default.
• W2954859619 cites W2036463953 @default.
• W2954859619 cites W2042255927 @default.
• W2954859619 cites W2051432939 @default.
• W2954859619 cites W2053460832 @default.
• W2954859619 cites W2054504338 @default.
• W2954859619 cites W2065198720 @default.
• W2954859619 cites W2073419672 @default.
• W2954859619 cites W2076939347 @default.
• W2954859619 cites W2081662013 @default.
• W2954859619 cites W2088747545 @default.
• W2954859619 cites W2097033712 @default.
• W2954859619 cites W2097945491 @default.
• W2954859619 cites W2098230015 @default.
• W2954859619 cites W2104360894 @default.
• W2954859619 cites W2112855745 @default.
• W2954859619 cites W2145246933 @default.
• W2954859619 cites W2153530160 @default.
• W2954859619 cites W2225102830 @default.
• W2954859619 cites W2313738200 @default.
• W2954859619 cites W2330352564 @default.
• W2954859619 cites W2479103426 @default.
• W2954859619 cites W2530952499 @default.
• W2954859619 cites W2589388440 @default.
• W2954859619 cites W2608395589 @default.
• W2954859619 cites W2781713682 @default.
• W2954859619 cites W2916426823 @default.
• W2954859619 doi "https://doi.org/10.1016/j.ijrobp.2019.06.2506" @default.
• W2954859619 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31254659" @default.
• W2954859619 hasPublicationYear "2019" @default.
• W2954859619 type Work @default.
• W2954859619 sameAs 2954859619 @default.
• W2954859619 citedByCount "9" @default.
• W2954859619 countsByYear W29548596192020 @default.
• W2954859619 countsByYear W29548596192021 @default.
• W2954859619 countsByYear W29548596192022 @default.
• W2954859619 countsByYear W29548596192023 @default.
• W2954859619 crossrefType "journal-article" @default.
• W2954859619 hasAuthorship W2954859619A5009234970 @default.
• W2954859619 hasAuthorship W2954859619A5015237674 @default.
• W2954859619 hasAuthorship W2954859619A5045431626 @default.
• W2954859619 hasAuthorship W2954859619A5075569712 @default.
• W2954859619 hasAuthorship W2954859619A5078538616 @default.
• W2954859619 hasConcept C121608353 @default.
• W2954859619 hasConcept C126322002 @default.
• W2954859619 hasConcept C126838900 @default.
• W2954859619 hasConcept C144301174 @default.
• W2954859619 hasConcept C207103383 @default.
• W2954859619 hasConcept C2775842073 @default.
• W2954859619 hasConcept C2777415128 @default.
• W2954859619 hasConcept C2778220009 @default.
• W2954859619 hasConcept C2989005 @default.
• W2954859619 hasConcept C38180746 @default.
• W2954859619 hasConcept C44249647 @default.
• W2954859619 hasConcept C50382708 @default.
• W2954859619 hasConcept C509974204 @default.
• W2954859619 hasConcept C71924100 @default.
• W2954859619 hasConceptScore W2954859619C121608353 @default.
• W2954859619 hasConceptScore W2954859619C126322002 @default.
• W2954859619 hasConceptScore W2954859619C126838900 @default.
• W2954859619 hasConceptScore W2954859619C144301174 @default.
• W2954859619 hasConceptScore W2954859619C207103383 @default.
• W2954859619 hasConceptScore W2954859619C2775842073 @default.
• W2954859619 hasConceptScore W2954859619C2777415128 @default.
• W2954859619 hasConceptScore W2954859619C2778220009 @default.
• W2954859619 hasConceptScore W2954859619C2989005 @default.
• W2954859619 hasConceptScore W2954859619C38180746 @default.
• W2954859619 hasConceptScore W2954859619C44249647 @default.
• W2954859619 hasConceptScore W2954859619C50382708 @default.
• W2954859619 hasConceptScore W2954859619C509974204 @default.
• W2954859619 hasConceptScore W2954859619C71924100 @default.
• W2954859619 hasFunder F4320337798 @default.
• W2954859619 hasIssue "2" @default.
• W2954859619 hasLocation W29548596191 @default.
• W2954859619 hasLocation W29548596192 @default.
• W2954859619 hasOpenAccess W2954859619 @default.
• W2954859619 hasPrimaryLocation W29548596191 @default.
• W2954859619 hasRelatedWork W1727188710 @default.
• W2954859619 hasRelatedWork W1799701121 @default.
• W2954859619 hasRelatedWork W2119154902 @default.

• next